Projected outcomes using a digital service model for COPD
CO2e emissions were projected to significantly decrease with a reduction in bed days, appointments and travel for 500 users with 70% of journeys made by car.
Let's look at what that means when considering how Lenus can transform the traditional COPD pathway.
How the Lenus Service can reduce emissions associated with healthcare resource utilisation
Kilograms of CO2e emissions saved annually with 500 service users
UK homes powered for one year by equivalent emissions from electricity production
More information on the data visualised
- Projections based on demonstrated reduction of 4.53 annual bed days and an investigator-estimated mean reduction of 3 face-to-face outpatient appointments per service user
- All CO2e emission reductions quantified using the Sustainable Healthcare Coalition’s care pathways carbon footprint calculator
- Average age of car on UK roads determined from data from the Society of Motor Manufacturers and Traders
- Average CO2 emissions per km driven for new cars in the EU each year between 2010 and 2020 determined from European Automobile Manufacturers Association data
- Average CO2e emissions per kWh from UK government data
- Average kWh electricity usage determined from UK government data
ClinicalTrials.gov Identifier: NCT04240353
The feasibility and service adoption observational cohort RECEIVER trial was commenced in September 2019 by NHS Greater Glasgow and Clyde to evaluate the implementation and efficacy of the Lenus COPD Service with high-risk COPD participants matched 1:5 to a control cohort using de-identified contemporary routine clinical data. In March 2021, 'RECEIVER' recruitment was paused and a 'Dynamic-Scot' cohort was established through remote recruitment in the Covid-19 service scale-up to routine care. The protocol is published here with the full results available here.
|Control||RECEIVER||Dynamic-Scot 1||Service users|
Selected from the NHS Greater Glasgow and Clyde SafeHaven dataset.
Diagnosis of COPD + a COPD-related hospital admission within a 14-day window of a reference RECEIVER trial participant's onboarding date were criteria for entry.
From these criteria, the optimal ~5 matches for each RECEIVER participant were determined based on sex and age whilst excluding duplicate control patients or individuals subsequently onboarded to Lenus COPD.
|At least one severe COPD exacerbation in the year prior to onboarding to Lenus COPD and/or chronic hypercapnic respiratory failure/sleep disordered breathing requiring NIV/CPAP treatment.||Onboarded at least 365 days before 31/08/2021 (the data censor date for analyses).||RECEIVER and Dynamic-Scot 1 participants.|
|1st Participant Index Date||3rd September 2019||3rd September 2019||15th May 2020||3rd September 2019|
|Censor Date||31st August 2021|
Medtech Innovation Briefing
The National Institute of Health and Care Excellence (NICE) has developed a medtech innovation briefing (MIB) on Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease available here.
Get in touch
Got a service in mind for Lenus? Talk to us today.